These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2563637)

  • 1. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats.
    Natorio Y; Hayakawa I; Shibata S
    Am J Pathol; 1989 Feb; 134(2):405-10. PubMed ID: 2563637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV.
    Natori Y; Hayakawa I; Shibata S
    Clin Exp Immunol; 1987 Nov; 70(2):434-9. PubMed ID: 2892601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria induced by anti-dipeptidyl peptidase IV (gp108); role of circulating and glomerular antigen.
    Natori Y; Shindo N; Natori Y
    Clin Exp Immunol; 1994 Feb; 95(2):327-32. PubMed ID: 7905795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antigens and antibody specificities involved in Heymann nephritis.
    Kamata K; Baird LG; Erikson ME; Collins AB; McCluskey RT
    J Immunol; 1985 Oct; 135(4):2400-8. PubMed ID: 2411795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term evolution of immune deposits in passive Heymann nephritis.
    Soares VA; Almeida DB
    Braz J Med Biol Res; 1992; 25(2):149-59. PubMed ID: 1339511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in rat: the effect of infusion of F(ab')2 fraction of anti-FX1(A) antibody.
    Sekse I; Iversen BM; Matre R; Ofstad J
    Nephron; 1991; 59(1):110-5. PubMed ID: 1944723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level.
    van Leer EH; Bruijn JA; Prins FA; Hoedemaeker PJ; de Heer E
    Lab Invest; 1993 May; 68(5):550-6. PubMed ID: 8098785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of antibody-mediated cytotoxicity and immune-complex formation to tubulointerstitial disease in passive Heymann nephritis.
    Eddy AA; Ho GC; Thorner PS
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):42-55. PubMed ID: 1728979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities.
    Natori Y; Hayakawa I; Shibata S
    Clin Exp Immunol; 1987 Jul; 69(1):33-40. PubMed ID: 2443290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains.
    Tiruppathi C; Miyamoto Y; Ganapathy V; Roesel RA; Whitford GM; Leibach FH
    J Biol Chem; 1990 Jan; 265(3):1476-83. PubMed ID: 1967253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis.
    Bruijn JA; van Leer EH; Baelde HJ; Corver WE; Hogendoorn PC; Fleuren GJ
    Lab Invest; 1990 Sep; 63(3):350-9. PubMed ID: 2395330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sequential glomerular eluates from rats with Heymann nephritis.
    Abrass CK
    J Immunol; 1986 Jul; 137(2):530-5. PubMed ID: 3487574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry.
    Hartel S; Gossrau R; Hanski C; Reutter W
    Histochemistry; 1988; 89(2):151-61. PubMed ID: 2456278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli.
    Leung CC; Cheewatrakoolpong B; O'Mara T; Black M
    Am J Anat; 1987 Jun; 179(2):169-74. PubMed ID: 3303894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.